Cibine [Cibinetide ARA-290 30mg] – 3 Vials – Corey Pauling

Laboratory: Corey Pauling
Form: Subcutaneous injection
Molecule: ARA-290 (Cibinetide)
Concentration: 10mg/vial
Volume: 3 + 3 vials
Research Dosage: 4 mg per day, administered subcutaneously. Cibine [10mg] contains Cibinetide (ARA-290), a synthetic peptide studied for its anti-inflammatory, neuroprotective, and tissue-protective properties. It may support recovery following physical stress, help regulate inflammatory processes, and support peripheral nerve and tissue protection. Human studies have primarily evaluated subcutaneous administration at 1 to 8 mg per day, with 4 mg/day being a commonly studied protocol. :contentReference[oaicite:0]{index=0}

Description and Effects

CIBINE [ARA-290 (Cibinetide) 10mg X 3 vials] is a synthetic 11-amino-acid peptide derived from erythropoietin (EPO), designed to activate the innate repair receptor involved in tissue protection and inflammatory regulation. For athletes and physically active individuals, Cibinetide is of particular interest for its potential to support recovery from physical stress, modulate inflammatory processes, and protect peripheral nerve and tissue structures.

Product Benefits

• Recovery Support: Supports mechanisms involved in tissue repair and recovery following physical stress and intense training.
• Inflammation Management: Helps regulate inflammatory processes associated with tissue stress and injury.
• Nerve Protection: Supports peripheral nerve function and has been studied for its effects on neuropathic symptoms and small nerve fiber damage.
• Tissue Protection: Activates repair mechanisms associated with protection against inflammatory and metabolic tissue damage.

Usage Guidelines

• Research Dosage: Clinical studies have evaluated 1–8 mg per day, with 4 mg administered subcutaneously once daily being one of the most extensively studied protocols.
• Duration of Use: Human studies have primarily used daily administration for 28 consecutive days.
• Method of Administration: Administered subcutaneously. Clinical studies have evaluated daily subcutaneous administration.

Precautions and Wellness

• Possible Side Effects: Clinical studies have generally reported good tolerability, with adverse events predominantly mild and transient.
• Injection Site: Clinical studies reported no significant pain or local irritation associated with subcutaneous administration.
• Monitoring: Monitor general tolerance, recovery, pain, and sensory function during use.
• Storage: Store in a cool, dry place and refrigerate after reconstitution.